SCOTUS Case Over Pesticides Sets Stage for Fight With ‘MAHA Moms’
A growing coalition of “Make America Healthy Again” activists is pressing the Trump administration to take a harder look at chemical exposure in everyday life—bringing their concerns directly to the White House just as a major Supreme Court case looms.
Among those attending the recent meeting was Casey Means, President Donald J. Trump’s nominee for surgeon general, alongside wellness influencers and concerned mothers who say public health priorities must shift heading into the midterms.
According to influencer Alex Clark, the discussion stretched for roughly two hours and included top administration officials such as Health and Human Services Secretary Robert F. Kennedy Jr. and White House Chief of Staff Susie Wiles.
“They just let us talk — they let us get everything off of our chest,” said Clark, who hosts “Culture Apothecary,” a podcast produced by Turning Point USA.
At the center of the conversation was glyphosate, the widely used herbicide found in Bayer’s Roundup product—long a flashpoint in debates over agriculture, regulation, and public health. Attendees urged officials to reassess its safety and consider restrictions, reflecting a broader push within the MAHA movement to limit pesticide exposure.
Their concerns come as the U.S. Supreme Court prepares to hear arguments in a pivotal case that could determine whether Americans can continue suing Bayer over alleged health risks tied to glyphosate.
The legal fight traces back to cases like that of DeWayne Lee Johnson, a California groundskeeper who was awarded a landmark judgment after claiming Roundup exposure caused his cancer. Though that award was later reduced on appeal, it opened the floodgates to thousands of similar lawsuits.
Bayer has consistently maintained that its product is safe, pointing to repeated findings from the Environmental Protection Agency that glyphosate is “not likely to be carcinogenic.” The company argues it should not face liability under state laws when its labeling complies with federal standards.
“It is time for the U.S. legal system to establish that companies should not be punished under state laws for complying with federal warning label requirements,” Bayer CEO Bill Anderson said in a statement earlier this year.
In a brief to the Court, U.S. Solicitor General D. John Sauer echoed that position, noting that federal regulators have repeatedly approved Roundup’s labeling without cancer warnings.
Despite that, pressure from MAHA-aligned activists continues to build. Hundreds of demonstrators are expected to rally outside the Court, with lawmakers from both parties—including Rep. Thomas Massie and Sen. Cory Booker—set to join calls for tighter pesticide oversight.
The issue has exposed a growing divide within conservative circles. While traditional free-market advocates emphasize regulatory consistency and deference to federal agencies, MAHA supporters argue that corporate influence has overshadowed legitimate health concerns—and are demanding stronger action from within their own political coalition.
For his part, Kennedy has long been a critic of glyphosate and previously pledged to curb pesticide use. Yet the Trump administration has also signaled support for domestic agricultural production and emphasized that agencies—not courts—should ultimately determine chemical safety standards.
Insiders say the White House meeting, coordinated in part by Erika Kirk and allies within the administration, reflects a broader effort to maintain unity within the coalition that helped power President Trump’s return to office in 2024.
With the Supreme Court’s decision expected in June, the outcome could have sweeping implications—not just for Bayer, but for the balance between federal authority, corporate accountability, and a grassroots movement increasingly determined to reshape health policy from the ground up.